DPIIT recognised startup Government of India
Startup India
Newworld Pharmaceuticals Private Limited
Newworld Pharmaceuticals Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹26.52 Lakh
▲ 29% YoY
Net profit · FY 2025
₹19,512
Net margin 0.7%
EBITDA · FY 2025
₹32,318
EBITDA margin 1.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Newworld Pharmaceuticals Private Limited
Data last updated:
Newworld Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2017PTC042138. Its GSTIN is 23AAFCN4523R1Z5 (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Smriti and Shilpi Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 203 Anurag Appartment 44 Mahaveer Nagar Near Bengali Square, Indore, Madhya Pradesh, India – 452018.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.52 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹19,512 (net margin 0.7%) and EBITDA of ₹32,318 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years and 30% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MP2017PTC042138
Registration Number 042138
Incorporation Date 05 January 2017
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Newworld Pharmaceuticals
Contact details
Newworld Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 203 Anurag Appartment 44 Mahaveer Nagar Near Bengali Square, Indore, Madhya Pradesh, India – 452018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Newworld Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Newworld Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Newworld Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Newworld Pharmaceuticals Private Limited, buy the company report.
Financials of Newworld Pharmaceuticals Private Limited
FY 2025 filings availableNewworld Pharmaceuticals Private Limited reported revenue of ₹26.52 Lakh (up 29% YoY) for FY 2025.
Revenue · FY 2025
₹26.52 Lakh ▲ 29%
Net profit · FY 2025
₹19,512 margin 0.7%
EBITDA · FY 2025
₹32,318 margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 46%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 102%
3 years · compounded
▲ 50%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 29% growth in the latest year. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32,318 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,512 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Newworld Pharmaceuticals Private Limited, buy the company report.
Board of directors of Newworld Pharmaceuticals Private Limited
Newworld Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smriti | Director | 05 Jan 2017 | 9 Years 9 Months | Current |
| Shilpi Singh | Director | 20 Sep 2021 | 5 Years 1 Months | Current |
| Preeti Singh | Director | 08 May 2025 | 1 Years 5 Months | Current |
Peer comparison
Newworld Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Expel Pharma Private Limited | ₹26.59 Lakh (FY 2021) | -31.0% | Bhiwandi, Maharashtra, India | |||
| V Mac Pharma Private Limited | ₹26.58 Lakh (FY 2017) | -52.0% | Jalgaon, Maharashtra, India | |||
| Newworld Pharmaceuticals Private Limitedthis company | ₹26.52 Lakh (FY 2025) | ₹19,512 | 0.7% | 29.0% | Indore, Madhya Pradesh, India | |
| Topmed Pharmaceuticals Private Limited | ₹26.43 Lakh (FY 2025) | -7.0% | Sikar, Rajasthan, India | |||
| Velikan Dovera India Private Limited | ₹26.37 Lakh (FY 2025) | 9.0% | Dombivali, Maharashtra, India |
To see the full peer comparison of Newworld Pharmaceuticals Private Limited, buy the company report.
Auditor
Newworld Pharmaceuticals Private Limited is audited by PUROHIT & JOSHI for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PUROHIT & JOSHI | FY 2020 | 009276C |
Shareholding
The shareholding of Newworld Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Newworld Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Newworld Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Newworld Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Newworld Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAFCN4523R1Z5 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Newworld Pharmaceuticals Private Limited, buy the company report.
Recent activity
Newworld Pharmaceuticals Private Limited has 7 board changes on record since 2017: 3 appointments and 4 cessations. The latest: Preeti Singh ceased to be Additional Director on 29 Sep 2025.
AGM
Newworld Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Preeti Singh ceased to be Additional Director.
Appointed
Preeti Singh was appointed as Director.
Filing
Newworld Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Ceased
Shilpi Singh ceased to be Additional Director.
Ceased
Bindu Singh ceased to be Additional Director.
Appointed
Shilpi Singh was appointed as Director.
Ceased
Amod Kumar Singh ceased to be Director.
Appointed
Smriti was appointed as Director.
Incorporation
05 Jan 2017
Newworld Pharmaceuticals Private Limited was registered on 05 Jan 2017 with Roc Gwalior & aged 9 years 9 months as per MCA records.
Frequently asked questions
Newworld Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 January 2017 (9+ years old) and is registered under CIN U74999MP2017PTC042138.
Newworld Pharmaceuticals has 3 current directors:
- Smriti - Director
- Shilpi Singh - Director
- Preeti Singh - Director
The latest financial statements of Newworld Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Newworld Pharmaceuticals is 23AAFCN4523R1Z5, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Newworld Pharmaceuticals is U74999MP2017PTC042138. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Newworld Pharmaceuticals was incorporated on 05 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Newworld Pharmaceuticals by revenue are Expel Pharma Private Limited, V Mac Pharma Private Limited, Topmed Pharmaceuticals Private Limited, Velikan Dovera India Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Preeti Singh ceased to be Additional Director on 29 Sep 2025. Preeti Singh was appointed as Director on 08 May 2025. Shilpi Singh ceased to be Additional Director on 29 Sep 2023. Newworld Pharmaceuticals has 7 board changes on record in total.
Yes, Newworld Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Newworld Pharmaceuticals is at Flat No. 203 Anurag Appartment 44 Mahaveer Nagar Near Bengali Square, Indore, Madhya Pradesh, India – 452018.
Newworld Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.